Sodium Carbonate → (S)-tert-butyl (1-((5-(2-chloro-4-(propylamino)pyrimidin-5-yl)-4-pentyn-1-yl)amino)-1-oxopropan-2-yl)(methyl)carbamate
反応式
[NH2:1][CH2:2][CH2:3][CH2:4][C:5]#[C:6][C:7]1[C:8]([NH:14][CH2:15][CH2:16][CH3:17])=[N:9][C:10]([Cl:13])=[N:11][CH:12]=1.[C:18]([N:25]([CH3:31])[C@H:26]([C:28](O)=[O:29])[CH3:27])([O:20][C:21]([CH3:24])([CH3:23])[CH3:22])=[O:19].Cl.C(N=C=NCCCN(C)C)C.C(N(CC)C(C)C)(C)C.C(=O)([O-])[O-].[Na+].[Na+]>CN(C)C=O.C(OCC)(=O)C>[Cl:13][C:10]1[N:9]=[C:8]([NH:14][CH2:15][CH2:16][CH3:17])[C:7]([C:6]#[C:5][CH2:4][CH2:3][CH2:2][NH:1][C:28](=[O:29])[C@@H:26]([N:25]([CH3:31])[C:18](=[O:19])[O:20][C:21]([CH3:22])([CH3:24])[CH3:23])[CH3:27])=[CH:12][N:11]=1参加物
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
To a solution of 5-(5-amino-1-pentyn-1-yl)-2-chloro-N-propylpyrimidin-4-amine (K2, 505 mg) and N-Boc-N-methyl-L-alanine (270 mg) in N,N-dimethylformamide (5 mL), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (635 mg) and N,N-diisopropylethylamine (378 μL) were added at room temperature, and the mixture was stirred overnight at the same temperature. To the reaction mixture, saturated aqueous sodium carbonate and ethyl acetate were added. The organic layer was separated, washed with water, and then dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. The obtained residue was purified by basic silica gel column chromatography (eluent, 50% hexane/50% ethyl acetate) to obtain (S)-tert-butyl (1-((5-(2-chloro-4-(propylamino)pyrimidin-5-yl)-4-pentyn-1-yl)amino)-1-oxopropan-2-yl)(methyl)carbamate (L1, 660 mg).
後処理
- customThe organic layer was separated
- washwashed with water
- dry with materialdried over anhydrous sodium sulfate
- customthe solvent was evaporated under reduced pressure
- customThe obtained residue was purified by basic silica gel column chromatography (eluent, 50% hexane/50% ethyl acetate)
出典と根拠
- ORDレコード
- ord-f9d88be0d8bf486b84af3da3c1e8571e
- 出典データセット
- uspto-grants-2015_09
- 特許番号
- US09145415B2
反応ノート
読み込み中…